We have a strong centralized management board led by Hans Schikan, our Chief Executive Officer, with broad experience in general management, strategy, corporate development, operations, in particular the commercialization of orphan drugs for rare diseases, information technology, finance, sales, communications and training. Many of our managing directors have worked together as a team for many years.
The Prosensa Management Board:
Hans GCP Schikan - Chief Executive Officer
Hans GCP Schikan, Chief Executive Officer is responsible for the overall management and strategic direction of Prosensa.
Berndt Modig - Chief Financial Officer
Berndt Modig is responsible for the financial management and strategy of Prosensa. He has more than 20 years of international experience in finance and operations, private equity and M&A.
Giles Campion - Chief Medical Officer & SVP R&D
Giles Campion, Chief Medical Officer and Senior Vice-President R&D is responsible for the company’s discovery and development strategy and activities.
Luc Dochez - Chief Business Officer & SVP Bus. Development
Luc Dochez, Chief Business Officer & SVP Business Development joined Prosensa in November 2008 and is responsible for all business and corporate development activities at the company.